Pfizer – Allergan

A new Pharma Mega-Deal making Botox and Viagra join forces. On November 23, 2015, Pfizer announced its $160bn tie-up with Allergan to form the world’s biggest pharmaceutical company by sales. Industry Overview Even though recent M&A activity has started to slow down in the healthcare sector, the announced merger shows that the M&A frenzy is … Continue reading Pfizer – Allergan

Financials on the rocks – FIG Market Update

The year 2015 has been marked by the acceleration of M&A activity in the financial sector, due to several distinct trends. Due to increased regulations, institutions must find new ways to not only adapt to the new expectations of regulators, but also to be proactive in finding sustainable business models. Higher capital requirements have put … Continue reading Financials on the rocks – FIG Market Update

JAPAN’S BATTLE AGAINST AN AGEING POPULATION: MITSUI SUMITOMO INSURANCE AND AMLIN FORM A WORLD-LEADING INSURANCE COMPANY

Mitsui Sumitomo Insurance Group will acquire British insurer Amlin Plc. The deal follows a recent trend of Japanese insurers turning to international acquisitions to hedge against the liability of Japans’ ageing population by providing additional channels for growth. The deal is mainly revenue driven, while another significant factor is expanding the geographic presence across Asia, … Continue reading JAPAN’S BATTLE AGAINST AN AGEING POPULATION: MITSUI SUMITOMO INSURANCE AND AMLIN FORM A WORLD-LEADING INSURANCE COMPANY

SHELL-BG, A NEW WAVE OF OIL M&A IS COMING?

On the morning of the 8th of April 2015 the acquisition of BG Group by the Anglo-Dutch oil giant Royall Dutch Shell was announced. It is considered to be the most expensive oil and gas deal in the past decade with an estimated value of around £47.0 billion ($70billion U.S. dollar). Structure of the Deal … Continue reading SHELL-BG, A NEW WAVE OF OIL M&A IS COMING?

A EUROPEAN FUND MANAGEMENT POWERHOUSE: SANTANDER AND UNICREDIT COMBINE THEIR ASSET MANAGEMENT UNITS

Banco Santander will combine its asset management arm with Pioneer Investments, a unit of Unicredit. The combined company will manage $429 bn in assets. This deal follows the recent trend in the M&A activity of Asset and Wealth Management firms. Enhancements to profitability, economies of scope and scale, and regulatory compliance are amongst the main … Continue reading A EUROPEAN FUND MANAGEMENT POWERHOUSE: SANTANDER AND UNICREDIT COMBINE THEIR ASSET MANAGEMENT UNITS

AN EMERGING INTERNATIONAL BANK: SABADELL BUYS TSB FOR £1.7 BN

Spanish institution Banco Sabadell (SAB.MC) agrees to pay £1.7 bn for TSB (TSB.L), Britain's seventh biggest lender with 631 branches and 4.3% market share, in one of the biggest cross-border banking deals since the financial crisis. Formally announced on March 12, the deal was also welcomed by the UK Treasury as “a vote of confidence … Continue reading AN EMERGING INTERNATIONAL BANK: SABADELL BUYS TSB FOR £1.7 BN

A SUBPRIME RENAISSANCE: CITIGROUP SELLS ONEMAIN TO SPRINGLEAF

Springleaf Holdings Inc. set to buy Citigroup Inc’s OneMain Financial Holdings for $4.25bn in cash, forming the largest subprime lender in the United States. Citigroup’s strategy to sell its non-core operations and focus on wealthier clients produces the combined entity with $15bn dollars in assets, 2000 branches, and a capacity to serve the growing subprime … Continue reading A SUBPRIME RENAISSANCE: CITIGROUP SELLS ONEMAIN TO SPRINGLEAF

GLAXOSMITHKLINE & NOVARTIS SWAP ASSTES WORTH £11BN

The asset-swap between GlaxoSmithKline (NYSE: GSK) and Novartis (NYSE: NVS) will lead to stronger focus by both companies on their current core activities. The transaction sets a new framework for future complex deals, where participants enhance their operations by divesting from non-profitable divisions, while acquiring assets that enhance the current portfolios. GSK’s position in vaccines … Continue reading GLAXOSMITHKLINE & NOVARTIS SWAP ASSTES WORTH £11BN

ACTAVIS ACQUIRES BOTOX-MAKER ALLERGAN FOR $66BN

The acquisition of Allergan Inc. (NYSE:AGN) by Actavis Plc. (NYSE:ACT) will lead to the creation of one of the biggest pharmaceutical companies in the world. The $66bn deal is expected to be closed by the second quarter of 2015. The acquisition by Actavis brings an end to the months-long pursuit of Allergan by the Canadian … Continue reading ACTAVIS ACQUIRES BOTOX-MAKER ALLERGAN FOR $66BN